Verastem (VSTM) Payables (2011 - 2026)
Verastem (VSTM) recorded quarterly Payables of $10.1 million in Q1 2026, down 18.61% quarter-over-quarter from $12.4 million in Q4 2025, and up 27.61% on a YoY basis from $7.9 million in Q1 2025.
Verastem (VSTM) Payables (2011 - 2026) Analysis & Trends
Verastem's Payables history runs 16 years deep, the most recent figure standing at $10.1 million for Q1 2026.
- In Q1 2026, Payables rose 27.61% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (up 27.61% YoY), while the FY2025 annual figure was $12.4 million, up 209.19% from the prior year.
- Payables was $10.1 million for Q1 2026 at Verastem, down from $12.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $12.4 million in Q4 2025 to a low of $1.7 million in Q2 2022.
- Historically, Payables has averaged $6.6 million across 5 years, with a median of $5.9 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Payables soared 736.04% in 2022, then plunged 43.96% in 2024.
- A 5-year view of Payables shows it stood at $5.2 million in 2022, then jumped by 38.79% to $7.2 million in 2023, then slumped by 43.96% to $4.0 million in 2024, then surged by 209.19% to $12.4 million in 2025, then dropped by 18.61% to $10.1 million in 2026.
- The last three Payables figures came in at $10.1 million (Q1 2026), $12.4 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 10.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.13 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Sep 30, 2025 | 10.08 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 7.94 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 4.57 Mn |
| Jun 30, 2024 | 7.20 Mn |
| Mar 31, 2024 | 8.36 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 5.91 Mn |
| Dec 31, 2022 | 5.18 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 641,000.00 |
| Jun 30, 2021 | 1.40 Mn |